Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen
- PMID: 32811798
- PMCID: PMC7853251
- DOI: 10.4103/ijmr.IJMR_3077_20
Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen
Conflict of interest statement
None
Comment in
-
Authors' response.Indian J Med Res. 2020 Jul & Aug;152(1 & 2):132-133. doi: 10.4103/0971-5916.292371. Indian J Med Res. 2020. PMID: 32811799 Free PMC article. No abstract available.
Comment on
-
Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19.Indian J Med Res. 2020 May;151(5):459-467. doi: 10.4103/ijmr.IJMR_2234_20. Indian J Med Res. 2020. PMID: 32611916 Free PMC article.
References
-
- Indian Council of Medical Research. Revised advisory on the use of Hydroxychloroquine (HCQ) as prophylaxis for SARS-CoV-2 infection (in supersession of previous advisory dated 23rd March, 2020) [accessed on June 30, 2020]. Available from: https://wwwicmrgovin/pdf/covid/techdoc/V5_Revised_advisory_on_the_use_of... .
-
- Temporary Methodical Recommendations. Prevention, diagnosis and treatment of new coronavirus infections (COVID-19) - Version 7 (released on June 3, 2020) [accessed on June 30, 2020]. Available from: https://rosomedru/system/documents/files/000/000/202/original/2020-06-03... .
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources